TipRanks
Advertisement

Integer Holdings Opens Convertible Notes Conversion Window

Integer Holdings Opens Convertible Notes Conversion Window
Story Highlights
  • Integer’s 2.125% Convertible Senior Notes became convertible for holders from October through December 2026 after its stock price exceeded 130% of the conversion threshold.
  • The new conversion window allows noteholders to exchange debt into cash and potentially equity at a set rate, which could alter Integer’s leverage and share count depending on uptake.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Integer Holdings ( (ITGR) ) has provided an update.

On October 2, 2026, Integer Holdings Corporation announced that its 2.125% Convertible Senior Notes due 2028 became convertible at the option of holders for the calendar quarter beginning October 1 and ending December 31, 2026. The Notes can be converted into cash up to their principal amount and, at the company’s election, into additional cash, shares of common stock or a combination of both for any conversion value exceeding principal.

The Notes became convertible after Integer’s common stock traded above 130% of the applicable conversion price for at least 20 days within the 30-day period ending September 30, 2026, reflecting a sustained share price increase. The conversion rate is set at 11.4681 shares per $1,000 principal amount, equivalent to a conversion price of about $87.20 per share, giving noteholders flexibility to realize value while potentially affecting Integer’s capital structure and share count depending on the level of conversions.

Integer has notified holders of the terms, conditions and procedures for exercising the conversion option and appointed Wilmington Trust, National Association, as conversion agent. The company emphasized that neither its board nor its employees are making recommendations on whether holders should convert, underscoring that the decision’s implications for individual investors will depend on their assessment of Integer’s stock performance and outlook.

This conversion window represents a key event in Integer’s management of its outstanding debt, creating a pathway for partial deleveraging if holders elect equity settlement. For stakeholders, the outcome of the conversion period may influence Integer’s leverage metrics, future financing flexibility and potential equity dilution, all of which can shape investor perception of the company’s financial strategy in the medical device CDMO sector.

The most recent analyst rating on (ITGR) stock is a Hold
with a $127.00 price target.
To see the full list of analyst forecasts on Integer Holdings stock,
see the ITGR Stock Forecast page.

Spark’s Take on ITGR Stock

According to Spark, TipRanks’ AI Analyst, ITGR is a Neutral.

The score is driven primarily by solid financial quality and improving free cash flow, supported by a bullish price trend. The pending $127/share all-cash acquisition and regulatory progress add a meaningful positive catalyst. These positives are tempered by sharply negative reported revenue growth, operating margin compression versus 2024, and a relatively high P/E with no dividend yield provided.

To see Spark’s full report on ITGR stock,
click here.

More about Integer Holdings

Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations, serving the cardio and vascular, neuromodulation and cardiac rhythm management markets. The company operates as a strategic partner for medical device customers, offering engineering and manufacturing capabilities under brands such as Greatbatch Medical and Lake Region Medical.

Integer focuses on advancing customers’ goals through quality-driven, innovative production of medical technologies, positioning itself as a key supplier within the global medical device supply chain. Its market role as a leading CDMO supports device makers seeking outsourced design, development and manufacturing expertise across specialized therapeutic areas.

The company’s presence in these high-value, technology-intensive segments underscores its importance to OEMs that rely on scalable manufacturing and regulatory-compliant processes. By combining contract development services with manufacturing, Integer can influence cost structures, time-to-market and product reliability for its medical device clients.

This positioning also means the company’s capital structure and financing decisions, including convertible debt instruments, can have implications not only for shareholders but also for customers that depend on long-term stability and investment in capacity and innovation.

Average Trading Volume: 996,635

Technical Sentiment Signal: Buy

Current Market Cap: $4.3B

Learn more about ITGR stock on TipRanks’ Stock Analysis page.

This story was written using TipRanks's AI tools and reviewed by a TipRanks editor.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1